Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C003001 |
7-ketocholesterol |
7-ketocholesterol affects the localization of BCL2L11 protein | affects localization | 15955068
|
C501332 |
ABT-737 |
ABT-737 inhibits the reaction [BCL2L11 protein binds to BCL2 protein] | affects binding|decreases reaction | 17097560
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of BCL2L11 mRNA | affects expression | 17562736
|
C103303 |
alitretinoin |
alitretinoin results in increased expression of BCL2L11 protein | increases expression | 16340750
|
C103303 |
alitretinoin |
seocalcitol inhibits the reaction [alitretinoin results in increased expression of BCL2L11 protein] | decreases reaction|increases expression | 16340750
|
D000638 |
Amiodarone |
Amiodarone results in increased expression of BCL2L11 mRNA | increases expression | 19774075
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of BCL2L11 mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of BCL2L11 mRNA | increases expression | 17530438
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in decreased expression of BCL2L11 mRNA | decreases expression | 18687144
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of BCL2L11 mRNA | increases expression | 15735009
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of BCL2L11 mRNA | decreases expression | 20713471
|
C400082 |
bortezomib |
bortezomib results in increased expression of BCL2L11 protein | increases expression | 16024631
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of BCL2L11 mRNA | increases expression | 17482686
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of BCL2L11 protein | increases expression | 17482686
|
D002251 |
Carbon Tetrachloride |
PLG protein affects the reaction [Carbon Tetrachloride results in increased expression of BCL2L11 protein] | affects reaction|increases expression | 17482686
|
D003474 |
Curcumin |
Curcumin results in increased expression of BCL2L11 mRNA | increases expression | 17332930
|
C057862 |
cyanoginosin LR |
cyanoginosin LR results in increased expression of BCL2L11 mRNA | increases expression | 17654400
|
C014347 |
decitabine |
decitabine results in decreased methylation of BCL2L11 promoter | decreases methylation | 19403302
|
C014347 |
decitabine |
decitabine results in increased expression of BCL2L11 mRNA | increases expression | 19403302
|
C014347 |
decitabine |
decitabine results in increased expression of BCL2L11 protein | increases expression | 19403302
|
D003907 |
Dexamethasone |
Dexamethasone results in increased expression of BCL2L11 mRNA | increases expression | 12782123
|
D004317 |
Doxorubicin |
BCL2L11 protein affects the susceptibility to [Doxorubicin co-treated with methylselenic acid] | affects cotreatment|affects response to substance | 17339365
|
D004317 |
Doxorubicin |
BCL2L11 protein affects the susceptibility to [Doxorubicin co-treated with Selenium] | affects cotreatment|affects response to substance | 17339365
|
D004317 |
Doxorubicin |
BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased cleavage of and results in increased activity of CASP9 protein] | affects cotreatment|increases activity|increases cleavage|increases reaction | 17339365
|
D004317 |
Doxorubicin |
BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein] | affects cotreatment|increases degradation|increases reaction | 17339365
|
D004317 |
Doxorubicin |
BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with Selenium] results in increased cleavage of and results in increased activity of CASP9 protein] | affects cotreatment|increases activity|increases cleavage|increases reaction | 17339365
|
D004317 |
Doxorubicin |
BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with Selenium] results in increased degradation of PARP1 protein] | affects cotreatment|increases degradation|increases reaction | 17339365
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of BCL2L11 protein | decreases expression | 17339365
|
C065180 |
fluvastatin |
[zoledronic acid co-treated with fluvastatin] results in increased expression of BCL2L11 mRNA | affects cotreatment|increases expression | 16996129
|
D005492 |
Folic Acid |
Folic Acid affects the expression of BCL2L11 mRNA | affects expression | 16361273
|
D005665 |
Furosemide |
Furosemide affects the expression of BCL2L11 mRNA | affects expression | 17497460
|
C056507 |
gemcitabine |
gemcitabine results in increased expression of BCL2L11 mRNA | increases expression | 17039268
|
C097613 |
imatinib |
BCL2L11 protein results in increased susceptibility to imatinib | increases response to substance | 19403302
|
D007530 |
Isoflurane |
Isoflurane results in decreased expression of BCL2L11 mRNA | decreases expression | 16978161
|
C005219 |
methyl cellosolve |
methyl cellosolve results in increased expression of BCL2L11 mRNA | increases expression | 19643169
|
D008769 |
Methylnitronitrosoguanidine |
[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein | affects cotreatment|decreases expression | 16030430
|
D008769 |
Methylnitronitrosoguanidine |
S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein] | affects cotreatment|decreases expression|decreases reaction | 16030430
|
C008493 |
methylselenic acid |
BCL2L11 protein affects the susceptibility to [Doxorubicin co-treated with methylselenic acid] | affects cotreatment|affects response to substance | 17339365
|
C008493 |
methylselenic acid |
BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased cleavage of and results in increased activity of CASP9 protein] | affects cotreatment|increases activity|increases cleavage|increases reaction | 17339365
|
C008493 |
methylselenic acid |
BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein] | affects cotreatment|increases degradation|increases reaction | 17339365
|
C008493 |
methylselenic acid |
methylselenic acid results in increased expression of BCL2L11 protein | increases expression | 17339365
|
C008542 |
monodansylcadaverine |
monodansylcadaverine results in increased expression of BCL2L11 protein | increases expression | 16170020
|
D009151 |
Mustard Gas |
Mustard Gas results in increased expression of BCL2L11 mRNA | increases expression | 18955075
|
D010634 |
Phenobarbital |
Phenobarbital results in decreased expression of BCL2L11 mRNA | decreases expression | 19270015
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of BCL2L11 mRNA | increases expression | 12832660
|
C025299 |
polyphenols |
polyphenols results in decreased expression of BCL2L11 mRNA | decreases expression | 16293270
|
C031280 |
pyrazole |
pyrazole results in increased expression of BCL2L11 mRNA | increases expression | 17945193
|
D020849 |
Raloxifene |
Raloxifene results in increased expression of BCL2L11 mRNA | increases expression | 19429434
|
C059514 |
resveratrol |
resveratrol results in increased expression of BCL2L11 protein | increases expression | 17636462
|
C065299 |
S-allylcysteine |
S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein] | affects cotreatment|decreases expression|decreases reaction | 16030430
|
C093642 |
SB 203580 |
SB 203580 inhibits the reaction [sodium arsenite results in increased phosphorylation of BCL2L11 protein] | decreases reaction|increases phosphorylation | 16818494
|
C515055 |
S-(dimethylarsino)-glutathione |
BCL2L11 protein affects the susceptibility to S-(dimethylarsino)-glutathione | affects response to substance | 19417148
|
C515055 |
S-(dimethylarsino)-glutathione |
S-(dimethylarsino)-glutathione results in increased expression of BCL2L11 mRNA | increases expression | 19417148
|
D012643 |
Selenium |
BCL2L11 protein affects the susceptibility to [Doxorubicin co-treated with Selenium] | affects cotreatment|affects response to substance | 17339365
|
D012643 |
Selenium |
BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with Selenium] results in increased cleavage of and results in increased activity of CASP9 protein] | affects cotreatment|increases activity|increases cleavage|increases reaction | 17339365
|
D012643 |
Selenium |
BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with Selenium] results in increased degradation of PARP1 protein] | affects cotreatment|increases degradation|increases reaction | 17339365
|
D012643 |
Selenium |
Selenium results in increased expression of BCL2L11 protein | increases expression | 17339365
|
C078903 |
seocalcitol |
seocalcitol inhibits the reaction [alitretinoin results in increased expression of BCL2L11 protein] | decreases reaction|increases expression | 16340750
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of BCL2L11 mRNA | decreases expression | 19822182
|
C017947 |
sodium arsenite |
BCL2L11 protein results in increased susceptibility to sodium arsenite | increases response to substance | 16818494
|
C017947 |
sodium arsenite |
SB 203580 inhibits the reaction [sodium arsenite results in increased phosphorylation of BCL2L11 protein] | decreases reaction|increases phosphorylation | 16818494
|
C017947 |
sodium arsenite |
sodium arsenite promotes the reaction [MAPK14 protein results in increased phosphorylation of BCL2L11 protein] | increases phosphorylation|increases reaction | 16818494
|
C017947 |
sodium arsenite |
sodium arsenite results in increased phosphorylation of BCL2L11 protein | increases phosphorylation | 16818494
|
D012965 |
Sodium Chloride |
[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein | affects cotreatment|decreases expression | 16030430
|
D012965 |
Sodium Chloride |
S-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in decreased expression of BCL2L11 protein] | affects cotreatment|decreases expression|decreases reaction | 16030430
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of BCL2L11 mRNA | increases expression | 15800033
|
C111237 |
vorinostat |
vorinostat results in increased expression of BCL2L11 protein | increases expression | 16144943
|
C088658 |
zoledronic acid |
[zoledronic acid co-treated with fluvastatin] results in increased expression of BCL2L11 mRNA | affects cotreatment|increases expression | 16996129
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
methyl cellosolve |
11.73 | 6499812 6474471 3652986 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
11.73 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
11.73 | 15322242 14514962 11752688 |
MESH:D000015 |
Abnormalities, Multiple |
|
imatinib |
4.85 | 18322153 |
MESH:D000022 |
Abortion, Spontaneous |
|
imatinib |
5.75 | 18322153 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.11 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
Folic Acid |
12.31 | 16316344 16595132 17003819 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
12.31 | 16538975 |
MESH:D058186 |
Acute Kidney Injury |
|
zoledronic acid |
12.31 | 19715164 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.70 | 18653653 |
MESH:D000210 |
Acute-Phase Reaction |
|
zoledronic acid |
5.03 | 20200999 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
6.34 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
6.34 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
6.34 | 17418594 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
9.74 | 6695378 |
MESH:D000236 |
Adenoma |
|
Folic Acid |
9.74 | 16963246 |
MESH:D000236 |
Adenoma |
|
resveratrol |
9.74 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
14.66 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
14.66 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
14.66 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.24 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.44 | 16712894 17306315 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
10.02 | 21441931 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
10.02 | 17308373 17451421 |
MESH:D019973 |
Alcohol-Related Disorders |
|
Curcumin |
4.62 | 17887948 |
MESH:D000544 |
Alzheimer Disease |
|
Curcumin |
8.48 | 15590663 |
MESH:D000544 |
Alzheimer Disease |
|
Folic Acid |
8.48 | 17116317 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
8.48 | 15800139 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
8.48 | 16162502 16183991 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.56 | 11748828 |
MESH:D000748 |
Anemia, Macrocytic |
|
methyl cellosolve |
5.88 | 3699323 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.38 | 10982225 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.63 | 19183758 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Amiodarone |
3.41 | 20041841 18218290 18057881 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
6.72 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
6.72 | 17115116 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Curcumin |
2.62 | 16807698 |
MESH:D053627 |
Asthenozoospermia |
|
methyl cellosolve |
5.07 | 3987992 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
2.56 | 10378619 |
MESH:D050197 |
Atherosclerosis |
|
7-ketocholesterol |
9.70 | 16632123 |
MESH:D050197 |
Atherosclerosis |
|
Curcumin |
9.70 | 18704882 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
9.70 | 16873680 17967414 |
MESH:D001281 |
Atrial Fibrillation |
|
Amiodarone |
3.56 | 18651412 19698954 |
MESH:D001284 |
Atrophy |
|
methyl cellosolve |
4.76 | 3699323 2626667 6705890 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.16 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Folic Acid |
2.16 | 21388746 |
MESH:D001327 |
Autoimmune Diseases |
|
Curcumin |
4.05 | 19761891 |
MESH:D001768 |
Blister |
|
Mustard Gas |
4.70 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Amiodarone |
18.63 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
18.63 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
18.63 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
18.63 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.33 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.46 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.24 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
imatinib |
9.72 | 15867366 |
MESH:D001859 |
Bone Neoplasms |
|
zoledronic acid |
9.72 | 15867366 16778634 16121404 19442620 11697798 17312309 |
MESH:D001862 |
Bone Resorption |
|
zoledronic acid |
4.30 | 16769263 18404659 15845617 8053405 11869084 18496637 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.03 | 16580743 |
MESH:D002545 |
Brain Ischemia |
|
Curcumin |
8.82 | 16770732 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
8.82 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Curcumin |
12.72 | 17596214 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
12.72 | 17150277 |
MESH:D001932 |
Brain Neoplasms |
|
monodansylcadaverine |
12.72 | 16170020 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
10.31 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
10.31 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Curcumin |
10.31 | 19250217 18593918 18462866 16243823 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
10.31 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
10.31 | 18628466 15939500 17983394 19526202 18234424 16096432 16595493 16264153 15136595 18695136 15634643 11325840 15567936 16115903 15993339 16826403 18382427 15994142 17426702 17369602 15692762 15668708 16322301 16935488 |
MESH:D001943 |
Breast Neoplasms |
|
Folic Acid |
10.31 | 16777985 |
MESH:D001943 |
Breast Neoplasms |
|
gemcitabine |
10.31 | 18382427 17039268 |
MESH:D001943 |
Breast Neoplasms |
|
imatinib |
10.31 | 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
10.31 | 17242785 17893378 17595753 15572757 15775269 17049068 16837676 17952589 16912660 17261762 17440819 15758505 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
10.31 | 17651959 16393696 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
10.31 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
vorinostat |
10.31 | 16144943 |
MESH:D001943 |
Breast Neoplasms |
|
zoledronic acid |
10.31 | 16096432 18695136 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
4.70 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
4.51 | 17687719 10378619 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.91 | 11589617 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.34 | 15673190 3786805 15721981 15700767 16227642 16192424 16011737 16050911 18705752 16097048 10355542 16124888 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.35 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Curcumin |
7.09 | 18593918 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.09 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
12.69 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
12.69 | 15073043 14691202 11135700 16217749 15553829 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
12.69 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
12.69 | 16234567 18059187 16023760 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
12.69 | 17173139 1701930 20007298 20935162 6705139 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
12.69 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
12.69 | 16507464 15276417 17306315 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.14 | 16675471 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bortezomib |
8.23 | 16052434 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Curcumin |
8.23 | 18414057 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
zoledronic acid |
8.23 | 19233551 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.41 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
6.22 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
zoledronic acid |
6.22 | 18507039 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.72 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
16.09 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Curcumin |
16.09 | 18462866 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
16.09 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
16.09 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
16.09 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
16.09 | 18572023 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
3.68 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.11 | 18850075 18670907 16120746 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.23 | 17382496 17519947 16952015 16364871 16278810 17329180 17007740 16612575 15792986 17131338 16455267 15476868 16242529 16731534 15811867 17308081 15505089 16109756 17924179 17974986 16651473 18627295 16269455 17351982 17928571 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Amiodarone |
5.40 | 15710769 19225199 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
5.40 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
Folic Acid |
10.49 | 16755160 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
10.49 | 15775269 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
10.49 | 15458977 |
MESH:D002341 |
Carotid Artery Thrombosis |
|
Amiodarone |
4.63 | 18974383 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.31 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitronitrosoguanidine |
6.14 | 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
6.14 | 19524636 20056578 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
3.81 | 4080065 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.78 | 16835633 |
MESH:D002764 |
Cholecystitis |
|
methyl cellosolve |
5.34 | 6499794 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.49 | 19176532 |
MESH:D002971 |
Cleft Lip |
|
Folic Acid |
3.73 | 21254359 |
MESH:D002972 |
Cleft Palate |
|
Folic Acid |
5.41 | 21254359 8946559 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.41 | 15668235 8697196 15340226 16354765 12621046 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.17 | 15800139 |
MESH:D003092 |
Colitis |
|
Curcumin |
13.54 | 16782535 16804969 18200517 |
MESH:D003092 |
Colitis |
|
resveratrol |
13.54 | 16474422 |
MESH:D003092 |
Colitis |
|
Selenium |
13.54 | 17936198 |
MESH:D003103 |
Coloboma |
|
Curcumin |
4.14 | 18809619 |
MESH:D003110 |
Colonic Neoplasms |
|
Curcumin |
9.99 | 19359593 16340194 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
9.99 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
9.99 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
polyphenols |
9.99 | 16293270 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
9.99 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
5.90 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
5.90 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
5.90 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Folic Acid |
5.90 | 16985020 17087956 17116713 16963246 17245555 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
5.90 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
methyl cellosolve |
8.16 | 12530607 6499821 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
8.16 | 17141729 14669216 |
MESH:D016510 |
Corneal Neovascularization |
|
Curcumin |
4.45 | 18497527 |
MESH:D003327 |
Coronary Disease |
|
fluvastatin |
7.91 | 16142594 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
7.91 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.75 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
4.98 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
4.98 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
imatinib |
4.98 | 18322153 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
4.98 | 20055451 10048152 15322242 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.68 | 15213294 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
3.78 | 17474826 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
2.99 | 12438553 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.20 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.40 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Curcumin |
6.48 | 18403477 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Folic Acid |
6.48 | 16886840 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.48 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Curcumin |
12.96 | 18204486 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
12.96 | 17451421 15920148 17308373 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
12.96 | 16286809 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
7.11 | 7237001 |
MESH:D003967 |
Diarrhea |
|
vorinostat |
7.11 | 20479100 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
22.81 | 19370779 12958197 10774834 11421492 14550746 17906064 12540782 11834606 12153990 16177239 11529661 19085960 16393943 19923254 12392966 16081117 11739529 17522070 11743745 19739265 16485898 2444490 17562736 11287661 18071297 16227642 14725611 19164858 10663392 16109766 10915739 14986274 19416960 12594235 12705907 15968718 18713872 15619225 16781746 19420014 11461765 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Amiodarone |
22.81 | 15265979 18218290 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
22.81 | 17522070 7120509 21278145 19336974 2869522 15998439 16227642 3786805 15027814 3732212 10092053 9327722 7179309 6623471 4309450 15968718 10915739 11566570 6884620 7440962 19085960 16177239 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
cyanoginosin LR |
22.81 | 17654400 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
22.81 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
polyphenols |
22.81 | 19370779 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
pyrazole |
22.81 | 12499123 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
22.81 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
22.81 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.63 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
6.98 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
6.98 | 11462148 |
MESH:D004381 |
Duodenal Ulcer |
|
Curcumin |
3.62 | 17351913 |
MESH:D004417 |
Dyspnea |
|
Furosemide |
4.48 | 16935035 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.59 | 1851702 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
4.03 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
31.22 | 19703484 |
MESH:D004487 |
Edema |
|
Furosemide |
31.22 | 11834646 |
MESH:D004487 |
Edema |
|
imatinib |
31.22 | 19703484 |
MESH:D004487 |
Edema |
|
Mustard Gas |
31.22 | 11428631 11428647 11402378 9260866 |
MESH:D004487 |
Edema |
|
pirinixic acid |
31.22 | 12083418 |
MESH:D004487 |
Edema |
|
Raloxifene |
31.22 | 15860553 |
MESH:D004487 |
Edema |
|
resveratrol |
31.22 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
31.22 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.44 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
7.99 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
7.99 | 17872969 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
4.65 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
6.91 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Folic Acid |
6.91 | 17301261 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.63 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.69 | 18037988 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.40 | 17923197 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.67 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.41 | 11558140 3922381 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.65 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.16 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
3.81 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.57 | 3659116 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
4.70 | 9357497 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
3.98 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
3.98 | 16530937 |
MESH:D017889 |
Exfoliation Syndrome |
|
Folic Acid |
5.04 | 16504073 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.67 | 11564622 |
MESH:D005221 |
Fatigue |
|
vorinostat |
5.14 | 20479100 |
MESH:D005234 |
Fatty Liver |
|
Amiodarone |
25.47 | 14986274 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
25.47 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
25.47 | 12795759 15959796 12631006 16045604 19224547 16239168 61145 17595544 |
MESH:D005234 |
Fatty Liver |
|
Curcumin |
25.47 | 19297423 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
25.47 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
25.47 | 17473493 |
MESH:D005264 |
Femoral Fractures |
|
zoledronic acid |
5.37 | 16234978 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.01 | 11858732 |
MESH:D005327 |
Fetal Resorption |
|
methyl cellosolve |
5.08 | 6474471 3987992 6499821 6499812 |
MESH:D020567 |
Fetal Weight |
|
methyl cellosolve |
5.34 | 6499821 6474471 6499812 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
10.47 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
imatinib |
10.47 | 17453242 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
12.26 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Curcumin |
12.26 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
12.26 | 20067830 |
MESH:D005532 |
Foot Deformities, Congenital |
|
methyl cellosolve |
5.05 | 3652986 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.83 | 16904648 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
9.73 | 16983495 |
MESH:D005756 |
Gastritis |
|
Folic Acid |
9.73 | 17171786 |
MESH:D005770 |
Gastrointestinal Neoplasms |
|
Curcumin |
4.25 | 18462866 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.22 | 16452187 |
MESH:D005901 |
Glaucoma |
|
Folic Acid |
4.66 | 16504073 |
MESH:D005909 |
Glioblastoma |
|
Curcumin |
10.52 | 17596214 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
10.52 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
monodansylcadaverine |
10.52 | 16170020 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.13 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Curcumin |
11.25 | 18829502 18462866 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
11.25 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
11.25 | 15692506 |
MESH:D034381 |
Hearing Loss |
|
Furosemide |
4.45 | 17868369 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
9.74 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Folic Acid |
9.74 | 17286298 16524890 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
9.74 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
6.78 | 14766674 18006777 16244372 16495754 16879835 17875725 16707910 16144979 18674790 12587719 16330681 17888722 16244371 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
6.78 | 11110106 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
14.54 | 17481944 |
MESH:D006333 |
Heart Failure |
|
Furosemide |
14.54 | 16845234 12660669 16011733 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
14.54 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
14.54 | 17162251 |
MESH:D006345 |
Heart Septal Defects, Ventricular |
|
methyl cellosolve |
5.32 | 6499821 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.50 | 15692506 |
MESH:D006461 |
Hemolysis |
|
methyl cellosolve |
4.99 | 17874071 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.93 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.17 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
Amiodarone |
17.04 | 15265979 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
17.04 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
17.04 | 18467677 19176532 16221962 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
17.04 | 15340226 12621046 16120746 |
MESH:D015417 |
Hereditary Sensory and Motor Neuropathy |
|
Curcumin |
4.60 | 17701891 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
2.90 | 7520565 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.73 | 16876885 |
MESH:D006679 |
HIV Seropositivity |
|
Folic Acid |
5.04 | 17209195 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
6.23 | 17606976 18501091 15147373 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
6.23 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.58 | 16354765 16959395 15340226 18606429 8697196 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
6.82 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
zoledronic acid |
6.82 | 16769263 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.08 | 16899240 |
MESH:D006934 |
Hypercalcemia |
|
bortezomib |
16.03 | 18089816 |
MESH:D006934 |
Hypercalcemia |
|
Furosemide |
16.03 | 17652376 |
MESH:D006934 |
Hypercalcemia |
|
zoledronic acid |
16.03 | 18089816 19622757 |
MESH:D053565 |
Hypercalciuria |
|
Furosemide |
5.20 | 17652376 |
MESH:D006937 |
Hypercholesterolemia |
|
Amiodarone |
13.06 | 8137927 9751232 |
MESH:D006937 |
Hypercholesterolemia |
|
Curcumin |
13.06 | 18704882 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
13.06 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.79 | 20558911 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Folic Acid |
4.11 | 16865747 16433478 16395265 16755160 16397167 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.61 | 16873680 |
MESH:D006962 |
Hyperparathyroidism, Secondary |
|
Furosemide |
5.41 | 15086907 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
10.90 | 17042910 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
10.90 | 17577099 15787275 |
MESH:D006973 |
Hypertension |
|
Sodium Chloride |
10.90 | 11507004 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
10.90 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.64 | 15338365 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Furosemide |
4.84 | 16612254 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.91 | 17488730 |
MESH:D006996 |
Hypocalcemia |
|
zoledronic acid |
5.73 | 12669777 |
MESH:C537153 |
Hypomagnesemia primary |
|
Furosemide |
5.20 | 11041285 |
MESH:D007019 |
Hypoproteinemia |
|
Furosemide |
5.41 | 16096441 |
MESH:D007022 |
Hypotension |
|
Furosemide |
8.48 | 11041285 |
MESH:D007022 |
Hypotension |
|
Isoflurane |
8.48 | 12967683 |
MESH:D007024 |
Hypotension, Orthostatic |
|
Furosemide |
4.95 | 15811171 |
MESH:D007037 |
Hypothyroidism |
|
Amiodarone |
4.07 | 17991464 18020914 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.20 | 17600658 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
9.65 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
methyl cellosolve |
9.65 | 3987992 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
9.65 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Curcumin |
16.72 | 16956363 18403477 17151092 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
16.72 | 8960868 11099482 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
16.72 | 9357497 8975870 17524151 11402378 16001271 11428620 11428647 11428631 9260866 |
MESH:D007249 |
Inflammation |
|
polyphenols |
16.72 | 16366677 |
MESH:D007249 |
Inflammation |
|
resveratrol |
16.72 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
16.72 | 12878042 12200463 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Curcumin |
3.01 | 18596194 18200517 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
9.54 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
9.54 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.33 | 16306350 |
MESH:D007414 |
Intestinal Neoplasms |
|
Curcumin |
3.83 | 10783313 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
2.93 | 16580747 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.18 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
12.26 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
12.26 | 15369732 15699352 16775033 |
MESH:D007674 |
Kidney Diseases |
|
Furosemide |
12.26 | 11041285 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
12.26 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
8.63 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
8.63 | 16518626 |
MESH:D007889 |
Leiomyoma |
|
Curcumin |
9.76 | 18555241 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
9.76 | 16973256 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Sodium Chloride |
4.56 | 9499605 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
9.17 | 15070760 |
MESH:D007938 |
Leukemia |
|
Curcumin |
9.17 | 18462866 |
MESH:D007938 |
Leukemia |
|
decitabine |
9.17 | 18980019 19235587 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.69 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
19.90 | 12560223 17077332 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
bortezomib |
19.90 | 18089816 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Curcumin |
19.90 | 16106398 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
zoledronic acid |
19.90 | 18089816 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.85 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
7.74 | 14633726 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
imatinib |
7.74 | 19208803 17301526 15107311 15748426 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
13.84 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
13.84 | 17236224 19117987 18454857 |
MESH:D007951 |
Leukemia, Myeloid |
|
imatinib |
13.84 | 17236224 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
ABT-737 |
8.09 | 17097560 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
8.09 | 17050201 16467208 20471514 19850784 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
bortezomib |
8.09 | 20471514 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
8.09 | 18460780 18206229 17679729 19010910 18704418 19387464 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.00 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
6.78 | 15622746 16331271 19075265 17869043 17649720 15748426 17712046 12679006 11468182 16966277 12018890 19225113 16112521 16330433 19642359 11161223 9834237 15336539 16823087 17217047 19035177 15213294 12712474 16891316 17107899 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
6.78 | 16087638 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
10.28 | 16882451 |
MESH:D015458 |
Leukemia, T-Cell |
|
Curcumin |
10.28 | 16106398 |
MESH:D017880 |
Limb Deformities, Congenital |
|
methyl cellosolve |
4.17 | 6499821 |
MESH:D008064 |
Lipidoses |
|
Amiodarone |
3.18 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
5.76 | 16943688 21278145 11903743 17334410 17157831 16239168 16221502 11408273 17174718 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
5.76 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
9.83 | 15925388 16638106 18054572 14748882 18412020 18705752 18395914 17481882 12445418 18481824 12898905 14724832 18376398 15996030 18251166 18317297 16015684 12609069 17714472 18277467 12546737 18263696 15818738 15893842 14716496 15052691 17823541 12958196 12666154 18472094 15370692 15931870 14512876 18472332 17698563 12586293 12389079 16097048 17557913 15057751 18006644 12741479 14620537 17944888 17761835 16116963 16248980 17631135 17805973 11481614 15673190 12632512 18187930 15650968 15123356 18395095 18210741 18166357 12445421 17869086 17640975 16136751 17766677 20821823 17721639 15959796 18205269 16011737 18429990 14716833 15362042 18420326 15876570 12649538 12667390 17976157 16027843 17922224 18339082 17565644 17708605 17900296 12632514 16033810 18279442 16192424 10355542 18418968 15338365 18156304 15730626 13678700 17525996 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Curcumin |
9.83 | 18705752 18006644 17355460 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
9.83 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
9.83 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
imatinib |
9.83 | 16596278 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
9.83 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
9.83 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
14.06 | 12587719 16611625 11587558 19784758 19460945 12969438 16610002 19014921 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
14.06 | 17285989 15720792 16964402 16246199 15830285 |
MESH:D008107 |
Liver Diseases |
|
Curcumin |
14.06 | 16956363 |
MESH:D008107 |
Liver Diseases |
|
Folic Acid |
14.06 | 16877991 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
14.06 | 19363144 |
MESH:D008107 |
Liver Diseases |
|
polyphenols |
14.06 | 16698588 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.72 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
8.10 | 16871587 17185352 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
8.10 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
22.58 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
22.58 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
22.58 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
22.58 | 19482888 8742319 21047994 15975961 19812893 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
22.58 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
22.58 | 19812893 19073162 20405173 19321006 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
22.58 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
22.58 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
15.55 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
15.55 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
15.55 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
15.55 | 18308698 1399818 17172636 6150874 2563599 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
15.55 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
Amiodarone |
7.04 | 15350150 11989578 17391786 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
7.04 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Amiodarone |
10.60 | 12587719 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
10.60 | 18161513 18702808 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
10.60 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Amiodarone |
4.02 | 18516814 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
3.59 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
14.00 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
14.00 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
14.00 | 18816296 17053015 20135361 20464547 18569708 18520028 6695378 20064080 20869020 |
MESH:D008175 |
Lung Neoplasms |
|
Curcumin |
14.00 | 18462866 19359593 16243823 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
14.00 | 15824018 11195469 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
14.00 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
14.00 | 8781369 3148597 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
14.00 | 17306315 16712894 15276417 17077188 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
14.00 | 19555203 11884234 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Folic Acid |
3.20 | 17718048 |
MESH:D008223 |
Lymphoma |
|
bortezomib |
15.28 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Curcumin |
15.28 | 18462866 |
MESH:D008223 |
Lymphoma |
|
decitabine |
15.28 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
15.28 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
bortezomib |
9.35 | 16675587 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
9.35 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
7.65 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
7.65 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Curcumin |
10.09 | 16173963 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
10.09 | 15621674 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
vorinostat |
5.24 | 20479100 |
MESH:D008231 |
Lymphopenia |
|
methyl cellosolve |
5.32 | 3699323 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
3.80 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
11.90 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
11.90 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
11.90 | 15318939 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
zoledronic acid |
11.90 | 17312309 |
MESH:D019767 |
Maxillofacial Abnormalities |
|
Folic Acid |
5.24 | 16832597 |
MESH:D008527 |
Medulloblastoma |
|
bortezomib |
4.03 | 19213072 |
MESH:D008545 |
Melanoma |
|
Curcumin |
8.75 | 17885582 18462866 |
MESH:D008545 |
Melanoma |
|
decitabine |
8.75 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
8.75 | 16827129 |
MESH:D008545 |
Melanoma |
|
resveratrol |
8.75 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
8.75 | 19082730 16487513 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.12 | 19513568 |
MESH:D008569 |
Memory Disorders |
|
Curcumin |
3.73 | 17263510 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
12.95 | 16166281 16966607 18303189 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
12.95 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
12.95 | 15107826 |
MESH:D008654 |
Mesothelioma |
|
zoledronic acid |
12.95 | 16675582 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.97 | 17112576 |
MESH:D053842 |
Microsatellite Instability |
|
Methylnitronitrosoguanidine |
5.43 | 17671175 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.09 | 15792986 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.09 | 15863610 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.84 | 16381670 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.34 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
45.07 | 15949261 11468182 19417148 19549372 14977855 |
MESH:D009101 |
Multiple Myeloma |
|
bortezomib |
45.07 | 19112201 19112817 19372569 |
MESH:D009101 |
Multiple Myeloma |
|
Curcumin |
45.07 | 19372569 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
45.07 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
45.07 | 15744524 15867202 16118317 |
MESH:D009101 |
Multiple Myeloma |
|
fluvastatin |
45.07 | 16996129 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
45.07 | 16497877 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
45.07 | 16490592 17164350 16267019 17049120 17935668 14749477 |
MESH:D009101 |
Multiple Myeloma |
|
S-(dimethylarsino)-glutathione |
45.07 | 19417148 |
MESH:D009101 |
Multiple Myeloma |
|
zoledronic acid |
45.07 | 18089719 16996129 19621390 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
Curcumin |
10.90 | 17962980 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
10.90 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.06 | 16239165 |
MESH:D009181 |
Mycoses |
|
Amiodarone |
4.44 | 17974566 12754197 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.21 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
10.83 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
10.83 | 19157545 16882708 19010910 18608210 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
10.83 | 9809623 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
8.31 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
8.31 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
8.31 | 17188708 17125593 16525036 17015251 16317513 16456233 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
7.81 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
7.81 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.60 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.30 | 17322642 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.02 | 17484760 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.09 | 16343187 |
MESH:D009325 |
Nausea |
|
vorinostat |
5.06 | 20479100 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
8.89 | 16624393 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Curcumin |
8.89 | 18495463 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
8.71 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
imatinib |
8.71 | 15867366 |
MESH:D009362 |
Neoplasm Metastasis |
|
zoledronic acid |
8.71 | 17312309 15867366 19139120 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
13.18 | 16946489 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
13.18 | 11141357 |
MESH:D009369 |
Neoplasms |
|
decitabine |
13.18 | 17925555 19116145 19470736 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
13.18 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
13.18 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
7.76 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
7.76 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Curcumin |
9.84 | 12497104 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
imatinib |
9.84 | 17614352 |
MESH:D009397 |
Nephrocalcinosis |
|
Furosemide |
5.41 | 15086907 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.32 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.62 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
2.78 | 14600291 |
MESH:D009423 |
Nervous System Neoplasms |
|
Curcumin |
5.17 | 18462866 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
10.52 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Folic Acid |
10.52 | 17438019 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
10.52 | 12854658 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.02 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
7.12 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
7.12 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
3.98 | 17929310 |
MESH:D009503 |
Neutropenia |
|
Folic Acid |
8.21 | 16322990 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
8.21 | 7688884 16761898 |
MESH:D053206 |
Nocturnal Enuresis |
|
Furosemide |
5.41 | 17945291 |
MESH:D009765 |
Obesity |
|
Curcumin |
4.16 | 19297423 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.16 | 20558911 |
MESH:D009845 |
Oligospermia |
|
methyl cellosolve |
4.73 | 3987992 |
MESH:D010014 |
Osteolysis |
|
imatinib |
11.05 | 15867366 |
MESH:D010014 |
Osteolysis |
|
zoledronic acid |
11.05 | 15867366 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
3.91 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Curcumin |
10.39 | 18719352 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
10.39 | 17882678 19059307 15775268 |
MESH:D010024 |
Osteoporosis |
|
zoledronic acid |
10.39 | 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
8.81 | 15758505 17823083 17893378 15579764 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
8.81 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.75 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
9.98 | 19769630 16624393 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
Curcumin |
9.98 | 19020741 18462866 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
9.98 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
9.98 | 15276417 17306315 |
MESH:D010146 |
Pain |
|
Acetaminophen |
5.76 | 16870215 |
MESH:D010146 |
Pain |
|
zoledronic acid |
5.76 | 16475674 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
14.40 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Curcumin |
14.40 | 19196508 17440100 19401701 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
14.40 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
gemcitabine |
14.40 | 16929163 18383843 18992248 17440100 11504793 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
14.40 | 16965848 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.74 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.78 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Isoflurane |
4.78 | 17414419 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.69 | 17983394 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.42 | 15087411 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.45 | 10923243 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.69 | 17638057 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
3.38 | 15727166 |
MESH:D011141 |
Polyuria |
|
Furosemide |
5.20 | 17945291 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
5.54 | 16144296 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.13 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
3.24 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
7.18 | 21297632 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
imatinib |
7.18 | 12476293 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
methyl cellosolve |
13.80 | 12530607 7974496 6499817 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
13.80 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
13.80 | 11399792 11222880 11896295 11118676 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.28 | 17616702 |
MESH:C536419 |
Primary sclerosing cholangitis |
marker/mechanism |
|
| 21151127 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
3.95 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.95 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Curcumin |
3.95 | 10851300 11398177 15129424 18156803 12497104 18226269 18769126 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.95 | 15749863 15897917 16888761 16868541 16729912 18437689 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
3.95 | 16205645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
3.95 | 16536755 15731164 16220300 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
3.95 | 17636462 17675339 17804756 17718901 16731767 15767336 |
MESH:D011471 |
Prostatic Neoplasms |
|
S-allylcysteine |
3.95 | 17155983 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.95 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
vorinostat |
3.95 | 17218635 |
MESH:D011471 |
Prostatic Neoplasms |
|
zoledronic acid |
3.95 | 19103299 12438248 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
3.64 | 18058305 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.03 | 12752131 |
MESH:D011656 |
Pulmonary Emphysema |
|
Curcumin |
4.13 | 19168576 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Amiodarone |
11.75 | 11597910 12832656 12490602 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
11.75 | 15814490 17322281 17365031 17975199 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
11.75 | 17894541 17720292 17620002 17266442 10334151 |
MESH:D011658 |
Pulmonary Fibrosis |
|
S-allylcysteine |
11.75 | 16614485 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.09 | 15770314 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
9.04 | 17922066 |
MESH:D051437 |
Renal Insufficiency |
|
Folic Acid |
9.04 | 15728788 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.12 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
Furosemide |
9.68 | 16526316 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
9.68 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
9.68 | 17520802 16314181 15827377 16317513 17058453 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Curcumin |
12.94 | 10666014 18379247 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
12.94 | 11700416 18379247 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Furosemide |
12.94 | 16096441 15912074 12394941 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.41 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
3.98 | 19155313 |
MESH:D012509 |
Sarcoma |
|
Curcumin |
8.26 | 18462866 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
8.26 | 15625365 18313854 17710206 15675481 16767912 17203757 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
14.86 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
14.86 | 16326096 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
zoledronic acid |
14.86 | 16121404 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.34 | 17846226 |
MESH:D012559 |
Schizophrenia |
|
Folic Acid |
2.83 | 16641680 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
2.40 | 4039156 3137016 11442880 16876388 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.37 | 6407741 |
MESH:D018805 |
Sepsis |
|
Curcumin |
8.58 | 18389075 |
MESH:D018805 |
Sepsis |
|
Isoflurane |
8.58 | 17414419 |
OMIM:609620 |
SHORT QT SYNDROME 1 |
|
Amiodarone |
4.63 | 18724381 |
MESH:D012871 |
Skin Diseases |
|
Folic Acid |
4.87 | 18709164 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
4.87 | 15451306 12880345 16961503 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
15.48 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
15.48 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
15.48 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
15.48 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
15.48 | 16192470 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
ABT-737 |
6.66 | 19010845 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.12 | 15625365 17203757 16767912 |
MESH:D013118 |
Spinal Cord Diseases |
|
Folic Acid |
5.04 | 16361298 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.44 | 12854658 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
3.87 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
9.49 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
9.49 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
9.49 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Folic Acid |
9.49 | 17171786 |
MESH:D013274 |
Stomach Neoplasms |
|
Furosemide |
9.49 | 17052386 |
MESH:D013274 |
Stomach Neoplasms |
|
imatinib |
9.49 | 15786421 |
MESH:D013274 |
Stomach Neoplasms |
|
Sodium Chloride |
9.49 | 16646055 |
MESH:D013276 |
Stomach Ulcer |
|
Amiodarone |
9.84 | 18087811 |
MESH:D013276 |
Stomach Ulcer |
|
Curcumin |
9.84 | 19188055 16631530 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
9.84 | 15138204 |
MESH:D020521 |
Stroke |
|
Folic Acid |
7.81 | 16517955 |
MESH:D020521 |
Stroke |
|
Raloxifene |
7.81 | 16837676 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.08 | 16321402 |
MESH:D013610 |
Tachycardia |
|
Amiodarone |
3.86 | 11238279 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Amiodarone |
3.76 | 19225199 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
polyphenols |
4.79 | 17997062 |
MESH:D013733 |
Testicular Diseases |
|
methyl cellosolve |
9.40 | 6499806 |
MESH:D013733 |
Testicular Diseases |
|
pyrazole |
9.40 | 6499806 |
MESH:D013921 |
Thrombocytopenia |
|
vorinostat |
4.58 | 20479100 |
MESH:D013959 |
Thyroid Diseases |
|
Amiodarone |
10.51 | 19731979 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
10.51 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
18.83 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
18.83 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
18.83 | 16010429 17909728 |
MESH:D013964 |
Thyroid Neoplasms |
|
imatinib |
18.83 | 16940797 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
18.83 | 1399818 |
MESH:D013971 |
Thyrotoxicosis |
|
Amiodarone |
4.42 | 18020914 19584973 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
4.74 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
3.82 | 16227395 |
MESH:D016171 |
Torsades de Pointes |
|
Amiodarone |
8.75 | 11989578 17467628 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
8.75 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
21.12 | 12845720 20435036 12973940 11780464 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
21.12 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Curcumin |
21.12 | 18593936 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
21.12 | 17616700 19087683 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
21.12 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
21.12 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
21.12 | 11723127 16452187 17306315 16712894 |
MESH:D014565 |
Urogenital Neoplasms |
|
Curcumin |
4.81 | 18462866 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.56 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
8.26 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
8.26 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
3.71 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
4.45 | 17785578 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
4.35 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
3.97 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.13 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
4.74 | 16837676 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
8.87 | 17334414 16364871 17638931 17678736 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
8.87 | 17488730 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.09 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.78 | 15886252 |